| Literature DB >> 33342261 |
Arman Fesharaki-Zadeh1, Jeremy T Miyauchi2, Karrah St Laurent-Arriot3, Stella E Tsirka2, Peter J Bergold3,4,5.
Abstract
Comorbid post-traumatic stress disorder with traumatic brain injury (TBI) produce more severe affective and cognitive deficits than PTSD or TBI alone. Both PTSD and TBI produce long-lasting neuroinflammation, which may be a key underlying mechanism of the deficits observed in co-morbid TBI/PTSD. We developed a model of co-morbid TBI/PTSD by combining the closed head (CHI) model of TBI with the chronic variable stress (CVS) model of PTSD and examined multiple behavioral and neuroinflammatory outcomes. Male C57/Bl6 mice received sham treatment, CHI, CVS, CHI then CVS (CHI → CVS) or CVS then CHI (CVS → CHI). The CVS → CHI group had deficits in Barnes maze or active place avoidance not seen in the other groups. The CVS → CHI, CVS and CHI → CVS groups displayed increased basal anxiety level, based on performance on elevated plus maze. The CVS → CHI had impaired performance on Barnes Maze, and Active Place Avoidance. These performance deficits were strongly correlated with increased hippocampal Iba-1 level an indication of activated MP/MG. These data suggest that greater cognitive deficits in the CVS → CHI group were due to increased inflammation. The increased deficits and neuroinflammation in the CVS → CHI group suggest that the order by which a subject experiences TBI and PTSD is a major determinant of the outcome of brain injury in co-morbid TBI/PTSD.Entities:
Keywords: astrocytes; behavior; cognition; macrophage/microglia; memory
Year: 2020 PMID: 33342261 PMCID: PMC7755938 DOI: 10.1177/1759091420979567
Source DB: PubMed Journal: ASN Neuro ISSN: 1759-0914 Impact factor: 4.146
Figure 1.CVS → CHI Impairs Performance on Barnes Maze and Active Place Avoidance. (a) On the 3rd and 4th day of Barnes testing, the CVS → CHI group had a significantly longer latency to find the escape hole than the other groups (*p < 0.01). (b) On the 4th, 6th, 7th, and 8th trials of active place avoidance testing, the CVS → CHI group CHI had significantly more entrances than the other groups (*p < 0.05). (c) The CVS → CHI group had a significantly shorter time to 1st entrance into the shock zone than the other groups (*p < 0.005). These data suggest that CVS → CHI produces behavioral deficits not seen in the other groups.
Parameters of Mouse Behavior.
| Sham-CHI | CHI | CVS | CHI→ CVS | CVS → CHI | |
|---|---|---|---|---|---|
| Barnes Maze | |||||
| Distance | 45.0 ± 2.1 | 49.5 ± 2.9 | 45.3 ± 2.2 | 46.3 ± 2.6 | 44.14 ± 2.2 |
| Primary errors on Day 4 | 2.9 ± 0.5 | 3.1 ± 0.6 | 4.4 ± 0.9 | 2.5 ± 0.8 | 7.3 ± 1.2* |
| Active Place Avoidance | |||||
| Distance Traveled on Habituation Trial | 45.0 ± 2.1 | 44.0 ± 5.5 | 45.3 ± 2.2 | 46.3 ± 2.6 | 43.7 ± 2.3 |
| Distance Traveled all other Trials | 22.8 ± 1.1 | 25.4 ± 1.3 | 23.6 ± 1.0 | 24.3 ± 1.8 | 27.6 ± 1.4 |
| Speed | 4.2 ± 0.2 | 4.6 ± 0.5 | 3.9 ± 0.1 | 3.9 ± 0.2 | 4.3 ± 0.3 |
| Linearity | 0.50 ± 0.03 | 0.58 ± 0.02 | 0.55 ± 0.02 | 0.48 ± 0.05 | 0.53 ± 0.02 |
| Average Total Shocks | 37.0 ± 3.9 | 34.7 ± 4.0 | 36.1 ± 5.7 | 31.3 ± 4.0 | 67.3 ± 8.9** |
| Average Total Entrances | 32.0 ± 3.4 | 32.1 ± 3.3 | 27.4 ± 3.0 | 24.8 ± 3.9 | 57.2 ± 6.4** |
| Average Shocks per Entrance | 1.23 ± 0.03 | 1.13 ± 0.04 | 1.25 ± 0.07 | 1.22 ± 0.08 | 1.17 ± 0.06 |
| Elevated Plus Maze | |||||
| Distance Traveled | 13.5 ± 2.0 | 16.4 ± 2.2 | 15.0 ± 2.8 | 14.8 ± 2.7 | 24.7 ± 2.2* |
On Barnes maze, distance traveled (in meters) had no treatment effect (F4,43 = 0.7, p > 0.5). On primary errors, there a significant effect of treatment and day with a significant interaction of treatment and day (treatment, F4,43 = 15.9, p < 0.005; day, F3,15 = 27.4, p < 0.001; interaction, errors, F6,368 = 27.9, p < 0.02) On day 4, the CVS → CHI group had significantly more errors than the other groups (*p < 0.05). On active place avoidance, treatment had no significant effect on distance traveled during habituation or training (habituation, F4,43 = 0.09, p < 1.0; training, F4,43 = 1.80, p < 0.9) nor did treatment have a significant effect on speed or linearity (speed, F4,43 = 1.26, p < 0.3; linearity, F4,43 = 2.10, p < 0.1). Average total shocks and shock zone entrances had a significant effect of treatment (shocks, F4,43 = 6.4, p < 0.01 entrances, F4,43 = 8.5, p < 0.001) with the CVS → CHI group having significantly more entrances and shocks than the other groups (**p > 0.005). Despite the CVS → CHI group receiving more shocks and more entrances, treatment showed no significant effect on shocks per entrance (F4,43 = 0.78, p < 0.5). On distance traveled on elevated plus maze, there was a significant effect of treatment (F4,43 = 2.7, p < 0.05) with the CVS → CHI traveling significantly more than the other groups (*p < 0.05).
Figure 2.CHI → CVS and CVS → CHI Produces Impairments on Elevated Plus Maze and CHI Impairs Acoustic Startle Response. A: The CVS, CHI → CVS and CVS → CHI groups had spent significantly more time in the open arm compared to the sham-treated group (CVS or CHI → CVS, **p < 0.001; CVS → CHI, *p < 0.05). The CVS, CHI → CVS and CVS → CHI groups also had significantly fewer entrances into open (Panel B) or closed (Panel C) arms (*p < 0.05). D: The CHI group had significantly more trials with behavioral freezing at 105 dB than the other groups (*p < 0.05).
Figure 3.CHI Activates Astrocytes in CA3. (a) Representative images of GFAP immunoreactivity in the CA3 region of the hippocampus. (b) The number of GFAP+ CA3 cells was significantly increased in the CHI group as compared to Sham-group (*p < 0.05). Scale bar, 100 μm.
Figure 4.CVS → CHI Increases Iba-1+ Cell Number in Multiple Hippocampal Regions. (a) Representative images of Iba-1 immunoreactivity in the dentate gyrus (top), CA3 (middle) or CA1 (bottom). Scale bar 100 μm. (b) Summary of Iba-1+ cell number. In all three hippocampal regions, the CVS → CHI group had significantly more Iba-1+ cells than the other groups (*p < 0.05). Scale bar, 100 μm.
Figure 5.Increased Hippocampal Arginase-1 Expression Following CHI, CVS, CHI → CVS, CVS → CHI. (a) Representative images of hippocampal arginase-1 immunofluorescence. (b) Summary of the changes in arginase-1 expression. Arginase-1 expression in the CHI, CVS, CHI → CVS, and CVS → CHI groups were significantly greater than the sham-treatment group (*p < 0.005, **p < 0.0005). Scale Bar, 100 μm.
Figure 6.Neuroinflammation in the Amygdala. (a) Representative images of Iba-1+ cells. (b) Summary of differences in Iba-1+ cell number. There were significantly more Iba-1+ cells in the CHI group than in the sham-treated group (*p < 0.05). (c) Representative images of GFAP+ cells in the amygdala. (d) There were significantly more GFAP+ cells in all experimental groups as compared to the sham-treated group (stats). Scale bar, 100 μm.
Figure 7.Inflammation in the Dentate Gyrus Correlates With Impaired Performance on Hippocampal-Dependent Tasks. The number of Iba-1+ cells in the dentate gyrus significantly correlated with average latency of the 4 trials on the first day of Barnes maze training (Panel A) (r2 = 0.77, p < 0.005) and with the number of entrances on trial 6 on active place avoidance (Panel B) (r2 = 0.64, p < 0.005).
Figure 8.CHI Increases Hippocampal BDNF Expression. A: Representative images of hippocampal BDNF immunofluorescence in the CA3 regions. B: Summary of differences in BDNF expression. The CHI group had significantly more BDNF expression than the sham-treated group (*p < 0.01).